Exports of drugs from the UK could be worth around L6 billion ($9.8billion) for 1996, based on 11-month figures, and this would produce a record trade surplus of about L2.5 billion, says the Association of the British Pharmaceutical Industry in its Annual Review.
Coming just ahead of the UK General Election, ABPI director general Trevor Jones says "these figures are an election reminder to politicians of all parties that our innovative industry does and will continue to make a major contribution to the economic wellbeing of the UK when it is given a fair opportunity to do so."
However, Dr Jones stresses that if the drug industry "is to thrive and continue to produce outstanding results....the domestic market - the National Health Service - must be forward-looking like the industry. There is no place for NHS schemes aimed at cutting the domestic medicines budget without any consideration of the effects on longer-term health and economic costs, patients' wellbeing, or the consequences for future industry research."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze